KPIs & Operating Metrics(New)
Growth Metrics

AbbVie (ABBV) EPS (Basic) Growth (5y) (2017 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -27.89%
Dec 31, 2025 152.19%
Sep 30, 2025 -40.13%
Jun 30, 2025 25.64%
Mar 31, 2025 -18.64%
Dec 31, 2024 -14.99%
Sep 30, 2024 -7.07%
Jun 30, 2024 9.46%
Mar 31, 2024 -14.14%
Dec 31, 2023 18.88%
Sep 30, 2023 -11.19%
Jun 30, 2023 -1.98%
Mar 31, 2023 -40.48%
Dec 31, 2022 115.37%
Sep 30, 2022 16.83%
Jun 30, 2022 -15.40%
Mar 31, 2022 18.69%
Dec 31, 2021 21.42%
Sep 30, 2021 12.91%
Jun 30, 2021 -15.76%
Mar 31, 2021 19.23%
Dec 31, 2020 -59.61%
Sep 30, 2020 11.63%
Jun 30, 2020 -20.57%
Mar 31, 2020 25.84%
Dec 31, 2019 41.57%
Sep 30, 2019 31.74%
Jun 30, 2019 -6.62%
Mar 31, 2019 22.02%
Dec 31, 2018 -30.31%
Sep 30, 2018 24.71%
Jun 30, 2018 13.46%
Mar 31, 2018 23.32%
Dec 31, 2017 -50.21%
Sep 30, 2017 0.20%
Jun 30, 2017 8.45%
Mar 31, 2017 13.83%